Brief: Gilead Donates Remdesivir Vials to Uganda for Ebola Bundibugyo Virus Outbreak Response Efforts
12/06/2026 13:30
BRIEF-Gilead Donates Remdesivir Vials to Uganda for Ebola Bundibugyo Virus Outbreak Response Efforts June 12 (Reuters) - Gilead Sciences, Inc GILD.O:
GILEAD: DONATES OVER 2000 VIALS OF REMDESIVIR TO UGANDA TO SUPPORT RESPONSE EFFORTS FOR EBOLA BUNDIBUGYO VIRUS DISEASE OUTBREAK
GILEAD: PREPARING TO SUPPORT REQUESTS FROM DRC, WHO & OTHER REGIONAL & GLOBAL PARTNERS FOR REMDESIVIR & OBELDESIVIR FOR EBOLA BVD
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gilead Sciences,
See all newsBrief: U.S. FDA Accepts Gilead’s Application For Investigational Once-Weekly Oral Yeztugo
Factbox: Global drugmakers invest billions to boost US presence
Brief: Gilead Donates Remdesivir Vials to Uganda for Ebola Bundibugyo Virus Outbreak Response Efforts
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: Major deals involving US drugmakers and biotechs over the past decade